Chile’s National Economic Prosecutor (FNE) has presented its counterpart, the Tribunal for the Defense of Free Competition (TDLC) with charges against local drug-makers Laboratorio Biosano, Fresenius Kabi Chile and its affiliate Laboratorio Sanderson. Authorities have accused the companies of forming a decade-long arrangement to rig government contract bidding. The labs are the country’s only makers of medical ampoules for generic medication.
The FNE charges accuse the labs of rigging bids for supplying the national health system by defining beforehand which of the two would be the winner of each contest. The cartel would coordinate reference prices and adjust their offers to ensure the ‘right’ company would win a specific contract.
The FNE has asked for a fine of 18 thousand UTA units for Sanderson and 2 thousand UTA units for Biosano, bringing the total to around $17 million USD. Biosano was able to avoid sanctions due to its cooperation under Chile’s leniency program for antitrust violators.
Full Content: La Tercera
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Canadian Breadmakers Settle Price-Fixing Lawsuit
Jul 25, 2024 by
CPI
EssilorLuxottica Open to Meta as Shareholder, Says CEO Francesco Milleri
Jul 25, 2024 by
CPI
California Supreme Court Upholds Proposition 22, Securing Independent Contractor Status for Uber and Lyft Drivers
Jul 25, 2024 by
CPI
Paramount Global Investor Sues to Block Skydance Media Merger
Jul 25, 2024 by
CPI
Software Vendors Win Class Action Status in Antitrust Case Against CDK Global
Jul 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – International Trade & Antitrust
Jul 26, 2024 by
CPI
What is Wrong with the WTO Discipline on Subsidies?
Jul 26, 2024 by
CPI
The Abiding Tension Between Trade Remedy Law and Antitrust
Jul 26, 2024 by
CPI
Trade and Antitrust: An End to Isolationism
Jul 26, 2024 by
CPI
International Trade Law and Domestic Regulation of Generative Artificial Intelligence: Divergent Approaches?
Jul 26, 2024 by
CPI